Alimentiv’s model attracts eyes across the medical community and beyond. Here are the latest stories people are telling about us, our mission and our unique Health Trust.
Alimentiv, Inc. formerly Robarts Clinical Trials, announced today a major rebranding to reflect the company’s continued growth as a specialized global gastrointestinal (GI) contract research organization (CRO).read more
ST. PAUL, Minn., June 25, 2020 (GLOBE NEWSWIRE) — Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ:OSUR), and Alimentiv Inc. (formerly Robarts Clinical Trials) today announced they have signed a collaboration agreement for a research study on patients with Acute Severe Ulcerative Colitis (ASUC).read more
Our corporate team "IBD Eliminators" are featured as the Corporate Team for Gutsy Walk! Including dedicated employees of Alimentiv Clinical Trials and supportive friends and family, our team has participated since 2017.read more
The appropriate location for biopsy sampling is a common question in gastrointestinal diseases such as Crohn’s disease (CD) and ulcerative colitis (UC). Standardization of biopsy procurement is essential during drug development to define response to therapy.read more